{"version":"1.0","type":"link","title":"Five-year follow-up of patients with relapsed/refractory mantle cell lymphoma treated with anti-CD19 CAR T-cell therapy in ZUMA-2, Cohorts 1 and 2.","author_name":"Muñoz J 외","author_url":"https://prs-insight.online/author/Mu%C3%B1oz%20J","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/158265","thumbnail_width":1200,"thumbnail_height":630}